Therapeutic Goods Administration logo
print this page decrease the text size increase the text size

Project milestones

The following dates reflect key decisions or actions in relation to formal cooperation between New Zealand and Australia in respect of the regulation of therapeutic products.

Date Description
June 2011


Statements by Australian Prime Minister - Julia Gillard and New Zealand Prime Minister John Key

July 2007 Suspension
December 2003 'Agreement Between the Government of Australia and the Government of New Zealand for the Establishment of a Joint Scheme for the Regulation of Therapeutic Products' signed
March 2003 Final report of Advertising Review released.
December 2002 Both the New Zealand Cabinet and Australian Government agree to the establishment of a trans Tasman agency to regulate therapeutic products.
June 2002 Joint (Australia/New Zealand) Discussion Paper 'A Proposal for a Trans-Tasman Therapeutic Agency to Regulate Therapeutic Products' released
July 2001 Australian Government agreed in principle to the establishment of a joint trans-Tasman agency to regulate therapeutic products.
December 2000 New Zealand Cabinet agreed in principle to the establishment of a joint trans-Tasman agency to regulate therapeutic products, subject to negotiation of governance arrangements satisfactory to New Zealand.
October 2000 Consulting company New Zealand Institute of Economic Research carried out a Regulatory Impact Analysis with respect to the proposed trans-Tasman regulator compared with a system that allows unilateral recognition by New Zealand of some other countries' regulatory decisions, and an analysis of the costs and benefits for Australia of setting up the proposed joint agency against the status quo.
June 2000 Joint (Aus/NZ) consultation paper released to stakeholder groups on a possible framework for a joint trans-Tasman agency to regulate therapeutic products.
May 2000 Australia established a Regulatory Reform Taskforce to review Australia's administrative arrangements for the regulation of public health and safety.
1999 New Zealand and Australian Health Ministers agreed that harmonisation of regulatory requirements for therapeutic products is likely to be the best option under the Trans-Tasman Mutual Recognition Arrangement (TTMRA). The Health Ministers, with their Trade and Commerce Minister colleagues, agreed that a project to explore the viability of establishing a joint trans-Tasman therapeutics regulator should be given priority on the TTMRA work programme.
May 1998 Trans-Tasman Mutual Recognition Act 1997 came into force. Special exemption applied to therapeutic products.
May 1993 Memorandum of Understanding signed between the TGA (Australia) and Medsafe (NZ) covering information exchanges and cooperation between the two regulators.

Top of page

Content last updated: 27 November 2012

Content last reviewed: 27 November 2012

Web page last updated: 7 May 2013


Site navigation





Historical information

Contact us